Mahindra Lifespace Developers Limited (NSE:MAHLIFE)
368.25
-4.30 (-1.15%)
Aug 1, 2025, 3:30 PM IST
NSE:MAHLIFE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
2,161 | 3,723 | 2,121 | 6,066 | 3,936 | 1,662 | Upgrade | |
Revenue Growth (YoY) | -28.49% | 75.52% | -65.04% | 54.14% | 136.72% | -72.79% | Upgrade |
Cost of Revenue | 1,715 | 3,164 | 1,915 | 5,217 | 3,129 | 1,263 | Upgrade |
Gross Profit | 446.1 | 558.9 | 205.6 | 849.04 | 806.73 | 399.55 | Upgrade |
Selling, General & Admin | 1,117 | 1,116 | 840.7 | 1,145 | 1,065 | 940.66 | Upgrade |
Other Operating Expenses | 1,162 | 1,141 | 1,076 | 688.83 | 491.66 | 393.97 | Upgrade |
Operating Expenses | 2,475 | 2,436 | 2,054 | 1,956 | 1,622 | 1,405 | Upgrade |
Operating Income | -2,029 | -1,877 | -1,848 | -1,107 | -815 | -1,005 | Upgrade |
Interest Expense | -173.1 | -193.8 | -73.9 | -102 | -64.66 | -93.57 | Upgrade |
Interest & Investment Income | - | - | - | 370.63 | 109.11 | 130.49 | Upgrade |
Earnings From Equity Investments | 2,475 | 1,860 | 1,795 | 1,181 | 902.63 | 121.14 | Upgrade |
Other Non Operating Income (Expenses) | 816.8 | 916 | 670.3 | 91.58 | 36.83 | 14.78 | Upgrade |
EBT Excluding Unusual Items | 1,090 | 705 | 542.9 | 434.25 | 168.9 | -832.13 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | -55.84 | -127.88 | 54.11 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | 0.23 | -16.64 | 0.23 | Upgrade |
Other Unusual Items | - | - | - | 677.98 | 968.42 | - | Upgrade |
Pretax Income | 1,090 | 705 | 542.9 | 1,057 | 992.81 | -777.78 | Upgrade |
Income Tax Expense | 91.5 | 91.5 | -440.1 | 28.33 | -624.3 | -63.31 | Upgrade |
Earnings From Continuing Operations | 998.7 | 613.5 | 983 | 1,028 | 1,617 | -714.47 | Upgrade |
Minority Interest in Earnings | -0.6 | -0.6 | -0.6 | -14.25 | -72.2 | -2.92 | Upgrade |
Net Income | 998.1 | 612.9 | 982.4 | 1,014 | 1,545 | -717.39 | Upgrade |
Net Income to Common | 998.1 | 612.9 | 982.4 | 1,014 | 1,545 | -717.39 | Upgrade |
Net Income Growth | -13.40% | -37.61% | -3.12% | -34.36% | - | - | Upgrade |
Shares Outstanding (Basic) | 156 | 155 | 155 | 155 | 154 | 154 | Upgrade |
Shares Outstanding (Diluted) | 156 | 155 | 155 | 155 | 155 | 154 | Upgrade |
Shares Change (YoY) | 0.56% | -0.02% | 0.21% | -0.14% | 0.63% | 0.03% | Upgrade |
EPS (Basic) | 6.38 | 3.95 | 6.34 | 6.56 | 10.01 | -4.65 | Upgrade |
EPS (Diluted) | 6.38 | 3.95 | 6.33 | 6.55 | 9.96 | -4.65 | Upgrade |
EPS Growth | -13.83% | -37.60% | -3.36% | -34.24% | - | - | Upgrade |
Free Cash Flow | - | -5,566 | -6,774 | -1,625 | -653.04 | -717.41 | Upgrade |
Free Cash Flow Per Share | - | -35.87 | -43.65 | -10.49 | -4.21 | -4.66 | Upgrade |
Dividend Per Share | - | 2.800 | 2.650 | 2.300 | 2.000 | - | Upgrade |
Dividend Growth | - | 5.66% | 15.22% | 15.00% | - | - | Upgrade |
Gross Margin | 20.64% | 15.01% | 9.69% | 14.00% | 20.50% | 24.03% | Upgrade |
Operating Margin | -93.88% | -50.41% | -87.15% | -18.25% | -20.71% | -60.45% | Upgrade |
Profit Margin | 46.19% | 16.46% | 46.32% | 16.72% | 39.26% | -43.15% | Upgrade |
Free Cash Flow Margin | - | -149.52% | -319.40% | -26.78% | -16.59% | -43.15% | Upgrade |
EBITDA | -1,840 | -1,699 | -1,711 | -1,014 | -782.58 | -979.6 | Upgrade |
EBITDA Margin | -85.16% | -45.63% | -80.67% | -16.72% | -19.89% | -58.92% | Upgrade |
D&A For EBITDA | 188.3 | 178.1 | 137.3 | 93.22 | 32.42 | 25.36 | Upgrade |
EBIT | -2,029 | -1,877 | -1,848 | -1,107 | -815 | -1,005 | Upgrade |
EBIT Margin | -93.88% | -50.41% | -87.15% | -18.25% | -20.71% | -60.45% | Upgrade |
Effective Tax Rate | 8.39% | 12.98% | - | 2.68% | - | - | Upgrade |
Revenue as Reported | 2,978 | 4,639 | 2,791 | 6,596 | 4,082 | 1,878 | Upgrade |
Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.